Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation
Successful Treatment of Pregnant and Postpartum Women With Severe COVID-19 Associated Acute Respiratory Distress Syndrome With Extracorporeal Membrane Oxygenation
复制标题
DOI：
10.1097/mat.0000000000001357
复制
发表时间：
2021-02-01
期刊：
影响因子：
4.2
通讯作者：
Anders, Marc
中科院分区：
文献类型：
--
作者：
Barrantes, Jairo H.;Ortoleva, Jamel;Anders, Marc
关于体外膜肺氧合（ECMO）用于患有COVID-19相关急性呼吸窘迫综合征（ARDS）的孕妇和围产期妇女的数据有限。孕妇可能会表现出更严重的COVID-19感染，需要重症监护。我们为9名患有COVID-19 ARDS的孕妇或围产期妇女提供了ECMO支持，所有人都幸存下来，并且没有发生ECMO的重大并发症。我们的病例系列表明，在COVID-19相关严重ARDS的管理中，ECMO支持的孕产妇生存率很高，这突出表明，在这场大流行期间，这些孕妇和产后患者应该得到ECMO的支持。
There are limited data on the use of extracorporeal membrane oxygenation (ECMO) for pregnant and peripartum women with COVID-19 associated acute respiratory distress syndrome (ARDS). Pregnant women may exhibit more severe infections with COVID-19, requiring intensive care. We supported nine pregnant or peripartum women with COVID-19 ARDS with ECMO, all surviving and suffering no major complications from ECMO. Our case series demonstrates high-maternal survival rates with ECMO support in the management of COVID-19 associated severe ARDS, highlighting that these pregnant and postpartum patients should be supported with ECMO during this pandemic.